DHA

Category
lipid
Routes
Oral (PO)
Half-Life (t½)
PO: 30h
Formula
C7H10O8
Molecular Weight
328.49 g/mol
PubChem CID
15608515
Aliases
Docosahexaenoic acid, C22:6n3

Pharmacological Mechanism

C22:6 ω-3 polyunsaturated fatty acid. Major structural lipid of neuronal + retinal membranes — ~30% of CNS phospholipid fatty acids. Critical for neurodevelopment in fetal life and CNS maintenance lifelong. Cardiovascular benefits parallel EPA.

Half-Life & Elimination Curve (PO: 30h)

100%50%25%12.5%0%0h0×t½30h1×t½60h2×t½3.8d3×t½5d4×t½6.3d5×t½0×t½ (0h): 100% remaining1×t½ (30h): 50% remaining2×t½ (60h): 25% remaining3×t½ (3.8d): 12.5% remaining4×t½ (5d): 6.3% remaining5×t½ (6.3d): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½30h50%
  • 2×t½60h25%
  • 3×t½3.8d12.5%
  • 4×t½5d6.3%
  • 5×t½6.3d3.1%
Elimination t½30h (PO)
Rate Constant (ke)0.0231 h⁻¹
97% Washout (5×t½)6.3d

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Top Dietary Sources

Chemical Structure & Identifiers